FeesSafety
Pluang+

Rail Vision completes key U.S. rail safety system testing under AAR's Technology Roadmap Program

Market News
10 Nov 2026, 14:32 WIB
GlobeNewsWire
View Source
Bullish
Rail Vision completes key U.S. rail safety system testing under AAR's Technology Roadmap Program

Rail Vision Ltd. successfully finished testing its AI-powered TrackScout™ railway safety system as part of the Association of American Railroads' Technology Roadmap Program. This milestone supports the advancement of next-generation rail safety and automation in North America, particularly enhancing Restricted Speed Enforcement capabilities. The company’s technology aims to improve situational awareness and operational safety, contributing to the rail industry's move toward more automated and autonomous train operations. Rail Vision’s participation highlights its growing role in transforming rail safety through AI-integrated sensing systems.

Rail Vision's successful completion of U.S. rail industry testing offers context for readers. For those following Industrials-sector stocks on Pluang, 50 of 135 stocks rose while 69 fell. Notable movers include FLNC at USD 5.48 with a 1-day change of +1.48%, DHT at USD 20.25 with a -1.46% change and 100% buy order activity, and FRO at USD 43.65 with a -1.46% change, as of Nov 10, 2026 18:42 WIB.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
57 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
57 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
57 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
57 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App